J9075 NDC Crosswalk, Billing Units, ASP Payment & Medicare Reimbursement

📋 J9075 summary

J9075 is a HCPCS Level II J-code used to bill cyclophosphamide, nos, billed per 5 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J9075: Cyclophosphamide(J9075)

Code J9075 Billing unit 5 MG Payment limit $0.575/unit NDC-Crosswalk 43 Quarter Q3 2026 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ9075

DescriptorInj, cyclophosphamide, nos

Billing unit5 MG

Payment limit / unit$0.575

Est. ASP / unit$0.542 est.

Mapped NDCs43

Data periodQ3 2026

Last updated2026-09-20

💊 About Cyclophosphamide Injection DRUG GUIDE

Cyclophosphamide is used in adults and children to treat several types of cancer.

These include malignant lymphomas (such as Hodgkin's disease and Burkitt's lymphoma), multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma and breast cancer.It is also used in children with biopsy-proven minimal change nephrotic syndrome (a kidney condition) who did not respond to, or cannot tolerate, steroid treatment.

It has not been shown to be safe and effective for nephrotic syndrome in adults or for other kidney diseases.

It is often combined with other cancer drugs.

Read the full Cyclophosphamide Injection drug guide →

Clinical overview from our editorial drug guide for Cyclophosphamide Injection. For billing reference, see the sections above.

🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026

📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).

Medicare payment limit / unit

$0.575

Est. ASP / unit

$0.542 est.

Est. after 2% sequester

$0.564

HCPCS dosage

5 MG

The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J9075 = 5 mg. Enter a regimen to convert dose → billing units and project a full course.

Dose per administration (mg) Frequency — every days Number of doses NDC / package billed (optional)

Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J9075 WITH EST. MEDICARE PAY

43 NDCs map to J9075. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.575/unit) × that package's bill units.

NDC (11-digit)	Drug	Labeler	Package	Strength	Bill units	Est. pay / pkg	NADAC / unit	Status	Source
00781-3233-94	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Sandoz	1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3233...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
00781-3244-94	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Sandoz	1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3244...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
00781-3255-94	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Sandoz	1 VIAL, SINGLE-DOSE in 1 CARTON (0781-3255...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
10019-0938-01	CYCLOPHOSPHAMIDE 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-938...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
10019-0939-01	CYCLOPHOSPHAMIDE 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-939...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
10019-0942-01	CYCLOPHOSPHAMIDE 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-942...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
10019-0943-01	CYCLOPHOSPHAMIDE 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-943...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
10019-0944-01	CYCLOPHOSPHAMIDE 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-944...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
10019-0945-01	CYCLOPHOSPHAMIDE 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-945...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
10019-0955-01	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-955...	500 mg/25mL	100	$57.50	—	● Active	CMS ASP
10019-0956-01	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-956...	1 g/50mL	200	$115.00	—	● Active	CMS ASP
10019-0957-01	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Baxter	1 VIAL, SINGLE-DOSE in 1 CARTON (10019-957...	2 g/100mL	400	$230.00	—	● Active	CMS ASP
16714-0857-01	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	NorthStar	1 VIAL, SINGLE-DOSE in 1 CARTON (16714-857...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
16714-0858-01	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	NorthStar	1 VIAL, SINGLE-DOSE in 1 CARTON (16714-858...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
16714-0859-01	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	NorthStar	1 VIAL, SINGLE-DOSE in 1 CARTON (16714-859...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
25021-0247-50	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	Sagent	1 VIAL in 1 CARTON (25021-247-50) / 25 mL...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
25021-0248-51	Cyclophosphamide 1 g/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	Sagent	1 VIAL in 1 CARTON (25021-248-51) / 50 mL...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
25021-0249-51	Cyclophosphamide 2 g/100mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	Sagent	1 VIAL in 1 CARTON (25021-249-51) / 100 m...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
39822-0250-01	CYCLOPHOSPHAMIDE 500 mg/25mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	XGen	1 VIAL, SINGLE-DOSE in 1 CARTON (39822-025...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
39822-0255-01	CYCLOPHOSPHAMIDE 1 g/50mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	XGen	1 VIAL, SINGLE-DOSE in 1 CARTON (39822-025...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
39822-0260-01	CYCLOPHOSPHAMIDE 2 g/100mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	XGen	1 VIAL, SINGLE-DOSE in 1 CARTON (39822-026...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
65219-0131-20	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Fresenius	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-131...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
65219-0133-20	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Fresenius	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-133...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
65219-0135-20	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Fresenius	1 VIAL, SINGLE-DOSE in 1 CARTON (65219-135...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
68001-0442-26	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	BluePoint	1 VIAL, SINGLE-DOSE in 1 CARTON (68001-442...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
68001-0443-27	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	BluePoint	1 VIAL, SINGLE-DOSE in 1 CARTON (68001-443...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
68001-0444-32	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	BluePoint	1 VIAL, SINGLE-DOSE in 1 CARTON (68001-444...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
70121-1238-01	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Amneal	1 VIAL, SINGLE-DOSE in 1 CARTON (70121-123...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
70121-1239-01	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Amneal	1 VIAL, SINGLE-DOSE in 1 CARTON (70121-123...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
70121-1240-01	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Amneal	1 VIAL, SINGLE-DOSE in 1 CARTON (70121-124...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
72572-0083-01	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Civica,	1 VIAL, SINGLE-DOSE in 1 CARTON (72572-083...	2 g/100mL	400	$230.00	—	● Active	CMS + PDAC
72572-0085-01	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Civica,	1 VIAL, SINGLE-DOSE in 1 CARTON (72572-085...	1 g/50mL	200	$115.00	—	● Active	CMS + PDAC
72572-0087-01	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Civica,	1 VIAL, SINGLE-DOSE in 1 CARTON (72572-087...	500 mg/25mL	100	$57.50	—	● Active	CMS + PDAC
72603-0104-01	Cyclophosphamide	Northstar	—	—	100	$57.50	—	—	CMS + PDAC
72603-0326-01	Cyclophosphamide	Northstar	—	—	200	$115.00	—	—	CMS + PDAC
81298-8110-01	Cyclophosphamide	Long	—	—	100	$57.50	—	—	CMS + PDAC
81298-8112-01	Cyclophosphamide	Long	—	—	200	$115.00	—	—	CMS + PDAC
81298-8114-01	Cyclophosphamide	Long	—	—	400	$230.00	—	—	CMS + PDAC
68001-0695-32	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	BluePoint	1 VIAL, SINGLE-DOSE in 1 CARTON (68001-695...	1 g/50mL	200	$115.00	—	● Active	PDAC
68001-0694-27	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	BluePoint	1 VIAL, SINGLE-DOSE in 1 CARTON (68001-694...	500 mg/25mL	100	$57.50	—	● Active	PDAC
42806-0902-26	Cyclophosphamide 1 g/50mL INJECTION, POWDER, FOR SOLUTION	Epic	1 VIAL, SINGLE-DOSE in 1 CARTON (42806-902...	1 g/50mL	200	$115.00	—	● Active	PDAC
42806-0901-26	Cyclophosphamide 500 mg/25mL INJECTION, POWDER, FOR SOLUTION	Epic	1 VIAL, SINGLE-DOSE in 1 CARTON (42806-901...	500 mg/25mL	100	$57.50	—	● Active	PDAC
42806-0903-26	Cyclophosphamide 2 g/100mL INJECTION, POWDER, FOR SOLUTION	Epic	1 VIAL, SINGLE-DOSE in 1 CARTON (42806-903...	2 g/100mL	400	$230.00	—	● Active	PDAC

NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

⚠️ Don't confuse J9075 with… RELATED CODES

Adjacent HCPCS codes that share an ingredient or formulation with J9075. Billing units and payment limits differ — confirm the exact code, strength and form before billing.

Code	Descriptor	Billing unit	Payment limit / unit	How it differs from J9075
J9072	Inj cyclophos dr.reddy's 5mg	5 MG	$8.922	Related ingredient or formulation — confirm strength, form and billing unit before substituting.
J9073	CYCLOPHOSPHAMIDE	5 MG	$0.498	Related ingredient or formulation — confirm strength, form and billing unit before substituting.
J9074	CYCLOPHOSPHAMIDE	5 MG	$3.438	Related ingredient or formulation — confirm strength, form and billing unit before substituting.
J9071	Inj cyclophosphamd auromedic	5 MG	$0.490	Related ingredient or formulation — confirm strength, form and billing unit before substituting.
J8530	Cyclophosphamide oral 25 mg	25 MG	$1.491	Different billing unit — 25 MG vs 5 MG
J9076	CYCLOPHOSPHAMIDE	5 MG	$4.387	Related ingredient or formulation — confirm strength, form and billing unit before substituting.

Related codes matched on shared ingredient (CMS Medicare Part B Spending feed). Billing units and payment limits from the CMS ASP Pricing File. Always verify the precise HCPCS code for the product and strength administered.

📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)

Period

Total Part B spend

$1.2M

Claims

8,806

Beneficiaries

3,700

Spend / beneficiary

$325.20

Spend / claim

$136.64

Trend by period

Where J9075 ranks among Part B drugs · 2026 (Q1) · neighbors ±5

Total spending — #362 of 824

#357 MARGENZA J9353 $1.31M #358 HELICOLL, PER SQUARE... Q4164 $1.27M #359 ELZONRIS J9269 $1.25M #360 SIMPLIMAX, PER SQ CM... Q4341 $1.25M #361 IMOVAX RABIES VACCIN... 90675 $1.21M #362 CYCLOPHOSPHAMIDE(J90... J9075 $1.2M #363 REVOSHIELD+ AMNIO, P... Q4289 $1.19M #364 RELEUKO Q5125 $1.19M #365 ENGERIX-B ADULT(9074... 90747 $1.16M #366 GLUCAGON EMERGENCY K... J1611 $1.16M #367 ALBUTEROL SULFATE(J7... J7613 $1.14M

Total claims — #170 of 824

#165 TRIESENCE J3300 9,687 #166 CYCLOSPORINE MODIFIE... J7515 9,668 #167 FOCINVEZ J1434 9,640 #168 ARALAST NP* J0256 9,390 #169 RENFLEXIS Q5104 9,046 #170 CYCLOPHOSPHAMIDE(J90... J9075 8,806 #171 AMINOPHYLLINE J0280 8,705 #172 LEVALBUTEROL HCL J7614 8,694 #173 PERJETA J9306 8,651 #174 ZIRABEV Q5118 8,636 #175 ILUMYA J3245 8,549

Full breakdown by period (2)

Period	Total spend	Beneficiaries	Claims	$/beneficiary	$/claim
2026 (Q1)	$1.2M	3,700	8,806	$325.20	$136.64
2025 (Q1-Q4)	$6.3M	11,289	39,276	$558.09	$160.41

Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.

📈 Medicare Part B claims detail CMS PSPS · 2024

Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.

Allowed charges

$1.45M

Medicare paid

$1.12M

Submitted services

2,161,299

Denial rate

6.7%

Allowed / service

$0.72

Submitted charges

$11.44M

Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.

🗺️ Where J9075 is utilized CMS · BY PROVIDER · 2024

Medicare Part B services for this code by the rendering provider's state — 69,825 services across 8 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.

Hover or tap a state to see its numbers + top ZIP codes.

Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.

📊 What bills under J9075

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient

cyclophosphamide 29

Cyclophosphamide 9

NDC products by labeler

Baxter Healthcare Company 6

Civica, Inc. 6

BluePoint Laboratories 5

Sandoz Inc. 3

NorthStar Rx LLC 3

Sagent Pharmaceuticals 3

XGen Pharmaceuticals DJB, Inc. 3

Epic Pharma, LLC 3

Related NDC directory pages

🧪 All Cyclophosphamide NDCsIngredient 🧪 All Cyclophosphamide NDCsIngredient 🏭 All Baxter labeler NDCsLabeler 10019 🏭 All Civica, labeler NDCsLabeler 72572 🏭 All BluePoint labeler NDCsLabeler 68001 🏭 All Sandoz labeler NDCsLabeler 00781

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.

HCPCS code & descriptor

CMS HCPCS Level II code file

Not available in current dataset

Payment limit & billing unit

CMS Medicare Part B ASP Pricing File (quarterly)

Q3 2026 · as of 2026-09-20

NDC ↔ HCPCS crosswalk

CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)

43 NDCs mapped

NADAC acquisition cost

CMS National Average Drug Acquisition Cost (weekly)

Not available for mapped NDCs

Utilization & spend

CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners

Latest data year 2026

Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J9075 billing FAQ

What is HCPCS code J9075?

J9075 is a HCPCS Level II J-code used to bill Inj, cyclophosphamide, nos under Medicare Part B and most medical (not pharmacy) benefits.

What is the billing unit for J9075?

One unit of J9075 represents 5 MG. Report the number of units equal to the dose administered divided by 5 MG.

How many units of J9075 should I bill?

Divide the dose administered by the code's unit size (5 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.

How much does Medicare pay for J9075?

The Medicare Part B payment limit is $0.575 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.564 per unit. Payment limits are revised quarterly.

Which NDCs bill under J9075?

43 NDCs currently map to J9075 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.

Does a crosswalk mean J9075 is covered?

No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.

J9075 – Inj, cyclophosphamide, nos · NDC Crosswalk & Billing Units